The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported hope, prognostic understanding, quality of life, symptom burden, coping mechanisms, and financial wellbeing in early phase clinical trial participants.
 
Debra Lundquist
No Relationships to Disclose
 
Sienna Durbin
No Relationships to Disclose
 
Andrea Pelletier
No Relationships to Disclose
 
Laura A Petrillo
No Relationships to Disclose
 
Viola Bame
Employment - Surface Oncology
 
Victoria Turbini
No Relationships to Disclose
 
Hope Heldreth
No Relationships to Disclose
 
Kaitlyn Lynch
No Relationships to Disclose
 
Jenipher Silva
No Relationships to Disclose
 
Casandra McIntyre
Consulting or Advisory Role - Putnam Associates
 
Dejan Juric
Stock and Other Ownership Interests - PIC Therapeutics; Relay Therapeutics; Vibliome Therapeutics
Consulting or Advisory Role - AstraZeneca; Eisai; EMD Serono; Genentech; Ipsen; MapKure; Novartis; PIC Therapeutics; Relay Therapeutics; Syros Pharmaceuticals; Vibliome Therapeutics
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Eisai (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Infinity Pharmaceuticals (Inst); InventisBio (Inst); Novartis (Inst); Pfizer (Inst); Ribon Therapeutics (Inst); Syros Pharmaceuticals (Inst); Takeda (Inst); Takeda (Inst)
 
Betty R. Ferrell
No Relationships to Disclose
 
Rachel Jimenez
Employment - Biogen (I)
Stock and Other Ownership Interests - Biogen (I)
 
Ryan David Nipp
No Relationships to Disclose